| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/20/2002 | EP1180017A1 Preparation for the application of anti-infective and/or anti-inflammatory agents |
| 02/20/2002 | EP1180014A2 Injectable anesthetic formulation |
| 02/20/2002 | EP0832120B1 Anti-fungal d-amino acid histatin-based peptides |
| 02/20/2002 | EP0749485B1 Antimicrobial proteins from impatiens |
| 02/20/2002 | EP0719137B1 Viscous surfactant emulsion compositions |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336934A Bis-amino acid sulfonamides containing N-terminally a substituted benzyl group as HIV protease inhibitors |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336817A Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 02/20/2002 | CN1336386A Giant web bombinator polypeptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336384A Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336383A Giant web bombinin and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
| 02/20/2002 | CN1336375A Spiro-and dicyclic diazine and carbozine oxazolidohne compound |
| 02/20/2002 | CN1336214A Traditional Chinese medicine for treating chronic bronchitis |
| 02/20/2002 | CN1336210A Farm animal and bird plague treating medicine powder |
| 02/20/2002 | CN1336198A Qinggangdan Lotion for washing feet to treat Hongkong foot |
| 02/20/2002 | CN1336197A Chinese medicine treating AIDS and its prepn. |
| 02/20/2002 | CN1336184A Baichun Prepn. for treating women's pelvic infection |
| 02/20/2002 | CN1336182A AIDS virus resisting Chinese medicine |
| 02/20/2002 | CN1336176A :Roxoithromycin suppostory and its prepn. |
| 02/19/2002 | US6348618 Beta-ketoester compounds |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348587 Purine or pyrimidine base derivatives; anticancer, antitumor and antiproliferative agents; treating hiv and hepatitis |
| 02/19/2002 | US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348482 Catechols as antimicrobial agents |
| 02/19/2002 | US6348477 Substituted phenyl thiazole derivatives as viricides |
| 02/19/2002 | US6348459 Sultam and sultone derived oxazolidinones |
| 02/19/2002 | US6348454 Bactericide antibiotics |
| 02/19/2002 | US6348342 Compounds |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348312 Oligonucleotide having length of 6-100 nucleotides, wherein at least one non-terminal pyrimidine nucleoside is modified, and also 5' and/or 3' ends are modified, by replacement of 3' and/or 5' phosphodiester bridge by phosphorothioate bridge |
| 02/19/2002 | US6348198 Isolated and purified from a bacterial pathogen selected from neisseria meningitidis, neisseria gonorrhoeae, moraxella catarrhalis, moraxella bovis and moraxella lacunata; immunogenic; |
| 02/19/2002 | US6348197 In ovo vaccination against Newcastle Disease |
| 02/19/2002 | US6348196 Feline polynucleotide vaccine formula |
| 02/19/2002 | US6348190 Pharmaceutical compositions with antimicrobial activity |
| 02/19/2002 | US6347633 Treatment of hepatitis C using hyperthermia |
| 02/19/2002 | CA2229786C Zwitterionic forms of trovafloxacin |
| 02/19/2002 | CA2024040C Dibenz [b,f] [1,4]oxazepin (and thiazepin)-11 (10h)-ones and-thiones and their use in the prevention or treatment of aids |
| 02/14/2002 | WO2002012900A1 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 02/14/2002 | WO2002012899A2 Peptides presented by cells |
| 02/14/2002 | WO2002012538A2 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012454A1 Virus-like micrograins and process for producing the same |
| 02/14/2002 | WO2002012421A1 Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012288A2 Vaccination against host cell-associated herpesviruses |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012271A2 Treatment of microbial infections with bacterial proteins and peptides |
| 02/14/2002 | WO2002012260A1 Macrolide antibiotics |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012225A1 Salts of benzimidazole compound and use thereof |
| 02/14/2002 | WO2002012211A1 Inverse thiazolyl amide derivatives |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012170A1 8-substituted tetracycline compounds |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011764A2 Pharmaceutical compositions |
| 02/14/2002 | WO2002011761A2 Vaccine against rsv |
| 02/14/2002 | WO2002011758A1 Vaccine against the influenza virus and method for producing said virus vaccine |
| 02/14/2002 | WO2002011751A2 Combinations of dalfopristine/quinupristine with cefpirome |
| 02/14/2002 | WO2002011746A2 Chlorella preparations exhibiting immunomodulating properties |
| 02/14/2002 | WO2002011742A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/14/2002 | WO2002011740A2 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 02/14/2002 | WO2002011728A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 02/14/2002 | WO2002011726A1 Highly absorbable solid preparation |
| 02/14/2002 | WO2002011724A2 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011710A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | WO2002011694A2 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | WO2002011676A2 Method of using diketopiperazines and composition containing them |
| 02/14/2002 | WO2002011666A2 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 02/14/2002 | WO2002011540A1 Rotavirus vaccine formulations |
| 02/14/2002 | WO2002011511A1 A novel polypeptide-the activating gtpase negative regulator 11.66 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | WO2001073080A3 Recombinant iron uptake proteins |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001068663B1 Nucleoside compounds and uses thereof |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 02/14/2002 | WO2001062283A3 Mucosal adjuvant formulation |
| 02/14/2002 | WO2001058933A3 Selective n-acylation of a82846 glycopeptide analogs |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001054675A3 Pharmaceutical compositions comprising terbinafine |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | WO2001049705A3 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |